Pharmaceutical-grade peptides from reputable suppliers undergo rigorous testing for purity, sterility, and accurate dosing
Full disclaimer 1.AOD-9604 is a 16-amino acid peptide fragment derived from human growth hormone (hGH residues 177-191) with added tyrosine, developed by Metabolic Pharmaceuticals for obesity treatment 2.Proposed mechanism: selective stimulation of lipolysis (fat breakdown) and inhibition of lipogenesis (fat formation) without growth hormone-like effects on IGF-1 or blood glucose 3.Failed Phase 2b clinical trial for obesity (2007)did not demonstrate statistically significant weight loss versus placebo, terminating clinical development for this indication 4.Received FDA "Generally Recognized as Safe" (GRAS) designation in 2023 as a food substance, but this is NOT a drug approval and does not establish efficacy for weight loss 5.Regulatory status: not FDA-approved as a drug, prohibited by WADA, and insufficient evidence for weight loss efficacy

Doctors here (state of Maryland, USA) are required to follow the standard of carenot just for PA, but for any condition that has an established standard of care
Are walk-in B12 shots really walk-in
Unlike full hGH, AOD9604 selectively promotes fat breakdown (lipolysis) without affecting IGF-1 levels or causing hyperglycemia, which makes it a safer alternative for targeting obesity-related concerns
Neither compound holds MHRA or EMA marketing authorisation